Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder with few medication options. Bumetanide, an FDA-approved diuretic, has been proposed as a viable candidate to treat core symptoms of ASD, however, neither the brain region related to its effect nor the cell-specific mechanism(...

Descripción completa

Detalles Bibliográficos
Autores principales: Lv, Hui, Gu, Xiao, Shan, Xingyue, Zhu, Tailin, Ma, Bingke, Zhang, Hao-Tian, Bambini-Junior, Victorio, Zhang, Tiantian, Li, Wei-Guang, Gao, Xiaoling, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179025/
https://www.ncbi.nlm.nih.gov/pubmed/35693812
http://dx.doi.org/10.3389/fimmu.2022.870577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179025/
https://www.ncbi.nlm.nih.gov/pubmed/35693812
http://dx.doi.org/10.3389/fimmu.2022.870577

Ejemplares similares